Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline

Article Types

Countries / Regions

Search Results (1)

Search Parameters:
Keywords = NAG-NAM disaccharide

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
27 pages, 4122 KiB  
Review
Assembly of Peptidoglycan Fragments—A Synthetic Challenge
by Fausto Queda, Gonçalo Covas, Sérgio R. Filipe and M. Manuel B. Marques
Pharmaceuticals 2020, 13(11), 392; https://doi.org/10.3390/ph13110392 - 15 Nov 2020
Cited by 6 | Viewed by 5030
Abstract
Peptidoglycan (PGN) is a major constituent of most bacterial cell walls that is recognized as a primary target of the innate immune system. The availability of pure PGN molecules has become key to different biological studies. This review aims to (1) provide an [...] Read more.
Peptidoglycan (PGN) is a major constituent of most bacterial cell walls that is recognized as a primary target of the innate immune system. The availability of pure PGN molecules has become key to different biological studies. This review aims to (1) provide an overview of PGN biosynthesis, focusing on the main biosynthetic intermediates; (2) focus on the challenges for chemical synthesis posed by the unique and complex structure of PGN; and (3) cover the synthetic routes of PGN fragments developed to date. The key difficulties in the synthesis of PGN molecules mainly involve stereoselective glycosylation involving NAG derivatives. The complex synthesis of the carbohydrate backbone commonly involves multistep sequences of chemical reactions to install the lactyl moiety at the O-3 position of NAG derivatives and to control enantioselective glycosylation. Recent advances are presented and synthetic routes are described according to the main strategy used: (i) based on the availability of starting materials such as glucosamine derivatives; (ii) based on a particular orthogonal synthesis; and (iii) based on the use of other natural biopolymers as raw materials. Full article
(This article belongs to the Special Issue Glycomimetics and Glycoconjugates in Drug Discovery)
Show Figures

Figure 1

Back to TopTop